Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling

Diabetic peripheral neuropathy (DPN) represents a severe microvascular condition that dramatically affects diabetic patients despite adequate glycemic control, resulting in high morbidity. Thus, recently, anti-diabetic drugs that possess glucose-independent mechanisms attracted attention. This work...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelkader, Noha F., Elbaset, Marawan A., Moustafa, Passant E., Ibrahim, Sherehan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pharmaceutical Society of Korea 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325846/
https://www.ncbi.nlm.nih.gov/pubmed/35767208
http://dx.doi.org/10.1007/s12272-022-01391-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325846/
https://www.ncbi.nlm.nih.gov/pubmed/35767208
http://dx.doi.org/10.1007/s12272-022-01391-5

Ejemplares similares